The effect of RAS/BRAF mutation status on survival and treatment efficacy in vulnerable older patients with metastatic colorectal cancer e a post-hoc exploratory analysis of the randomized NORDIC9-study

Aktivitet: Foredrag og mundtlige bidragKonferenceoplæg

Periode1. jul. 2023
BegivenhedstitelWorld Congress on Gastrointestinal Cancer 2023: ESMO GI
BegivenhedstypeKonference
PlaceringBarcelonaVis på kort
Grad af anerkendelseInternational